As TEG011 cells carry CD8α-dependent Vγ5Vδ1TCR, we focused our in vivo analysis to tumor-reactive CD8-expressing TEG cells (as validated by in vitro functional T cell assay in Figure 1D) while taking into account the non-tumor reactive CD4+ TEG cells. The gene discussed is CD8A; the disease is neoplasm.